07PN4KZ
Removal Lymphatic to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | P Removal |
| Body Part | N Lymphatic |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Taking out or off a device from a body part
Procedure Overview
This family covers taking out a device that was previously placed in a lymphatic or hemic structure, such as a drain left in the splenic bed after surgery, a catheter used to manage a lymphatic leak, or a mesh or other implant associated with the spleen or thymus. The device itself is being removed; no tissue is being cut away or repaired in the process. These procedures are typically staged after an earlier operation, once the device has served its purpose - controlling drainage, supporting healing, or monitoring a surgical site.
For patients, this is usually a straightforward, low-risk step in recovery rather than a major operation, though it is still coded as a distinct procedure because it involves entering the body to retrieve the device.
Anatomy & Axis Detail
Lymphatic
This category covers excision of lymphatic vessels or nodes from a body region rather than a named solitary organ, applicable to procedures like regional lymph node dissection or removal of diseased lymphatic channels affecting drainage from an extremity, the neck, or trunk. Lymphatic tissue here serves as a network of vessels and filtering nodes rather than a single discrete structure, so removal is typically driven by cancer staging, suspected malignant involvement, or lymphedema management rather than isolated organ disease. Because lymph nodes act as sentinels for metastatic spread, documentation must specify the body region and whether removal was partial, since the extent taken directly affects staging accuracy and subsequent treatment planning. This differs from removal of a solitary named lymphatic structure like the spleen or thymus, which are coded under their own specific body part values.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders need documentation identifying the specific device removed and confirming that removal is the entire action - if the surgeon also repairs tissue, replaces the device, or performs any other procedure during the same encounter, additional codes are needed alongside or instead of Removal. A frequent error is coding Removal when a device is actually being exchanged for a new one in the same body part; ICD-10-PCS handles a straight swap differently than a removal followed by a separate insertion. Another pitfall is confusing removal of a device from the lymphatic system with removal of a device from an adjacent structure (such as a vascular access line running near lymph nodes) - the device must be recorded against the lymphatic or hemic body part it was actually seated in.